tirzepatide for mash VisualAbstract: Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Liver Fibrosis was More Effective Than Placebo at Resolving Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis

This article is exclusive to STAT+ subscribers Unlock this article plus daily coverage and analysis of the biotech sector by subscribing to STAT+

it's essential to disclose your current medications during the online consultation so our healthcare professionals can advise you appropriately

That 6.5 percentage point difference is clinically significant and represents one reason many patients and providers prefer tirzepatide

Injecting a bacterially contaminated solution can cause injection site infections ranging from mild redness to serious abscesses, systemic infections if bacteria enter the bloodstream, and immune reactions that mimic allergic responses